40 related articles for article (PubMed ID: 20336744)
1. Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users.
Jamalidoust M; Namayandeh M; Moghadami M; Ziyaeyan M
Virol J; 2017 Jul; 14(1):127. PubMed ID: 28697809
[TBL] [Abstract][Full Text] [Related]
2. Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysis.
Polyak SJ; Sullivan DG; Austin MA; Dai JY; Shuhart MC; Lindsay KL; Bonkovsky HL; Di Bisceglie AM; Lee WM; Morishima C; Gretch DR;
Virol J; 2005 Apr; 2():41. PubMed ID: 15847697
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies.
Mao Q; Ray SC; Laeyendecker O; Ticehurst JR; Strathdee SA; Vlahov D; Thomas DL
J Virol; 2001 Apr; 75(7):3259-67. PubMed ID: 11238852
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity of near genome-wide hepatitis C virus sequences during chronic infection: evidence for protein structural conservation over time.
Li H; Hughes AL; Bano N; McArdle S; Livingston S; Deubner H; McMahon BJ; Townshend-Bulson L; McMahan R; Rosen HR; Gretch DR
PLoS One; 2011 May; 6(5):e19562. PubMed ID: 21573177
[TBL] [Abstract][Full Text] [Related]
5. Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression.
Netski DM; Mao Q; Ray SC; Klein RS
J Acquir Immune Defic Syndr; 2008 Oct; 49(2):136-41. PubMed ID: 18769357
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral Drug Concentrations in Lymph Nodes: A Cross-Species Comparison of the Effect of Drug Transporter Expression, Viral Infection, and Sex in Humanized Mice, Nonhuman Primates, and Humans.
Burgunder E; Fallon JK; White N; Schauer AP; Sykes C; Remling-Mulder L; Kovarova M; Adamson L; Luciw P; Garcia JV; Akkina R; Smith PC; Kashuba ADM
J Pharmacol Exp Ther; 2019 Sep; 370(3):360-368. PubMed ID: 31235531
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Naturally Occurring Resistant Mutations to Hepatitis C Virus NS3 Protease Inhibitors: A Preliminary Study in South of Iran.
Afrasiabi M; Hosseini SY; Yaghobi R; Fattahi MR; Ardebili M; Khodadad M
Jundishapur J Microbiol; 2015 Oct; 8(10):e24965. PubMed ID: 26587218
[TBL] [Abstract][Full Text] [Related]
8. Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity.
Martinez MA; Nevot M; Jordan-Paiz A; Franco S
J Virol; 2015 Oct; 89(19):9758-64. PubMed ID: 26178979
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfection.
Jabara CB; Hu F; Mollan KR; Williford SE; Menezes P; Yang Y; Eron JJ; Fried MW; Hudgens MG; Jones CD; Swanstrom R; Lemon SM
Antimicrob Agents Chemother; 2014 Oct; 58(10):6079-92. PubMed ID: 25092699
[TBL] [Abstract][Full Text] [Related]
10. IL28B polymorphism is not associated with HCV protease diversity in patients co-infected with HIV and HCV treated with pegylated interferon and ribavirin.
Osinusi A; Chary A; Winters MA; Naggie S; Masur H; Polis MA; Kottilil S; Holodniy M
J Med Virol; 2012 Oct; 84(10):1522-7. PubMed ID: 22930497
[TBL] [Abstract][Full Text] [Related]
11. Impact of interferon-ribavirin treatment on hepatitis C virus (HCV) protease quasispecies diversity in HIV- and HCV-coinfected patients.
Chary A; Winters MA; Kottilil S; Murphy AA; Polis MA; Holodniy M
J Infect Dis; 2010 Sep; 202(6):889-93. PubMed ID: 20677940
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.
Neau D; Jouvencel AC; Legrand E; Trimoulet P; Galperine T; Chitty I; Ventura M; Le Bail B; Morlat P; Lacut JY; Ragnaud JM; Dupon M; Fleury H; Lafon ME
J Med Virol; 2003 Sep; 71(1):41-8. PubMed ID: 12858407
[TBL] [Abstract][Full Text] [Related]
13. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
[TBL] [Abstract][Full Text] [Related]
14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in antiretroviral treatment and prevention in HIV-infected patients.
Maltêz F; Doroana M; Branco T; Valente C
Curr Opin HIV AIDS; 2011 Dec; 6 Suppl 1():S21-30. PubMed ID: 22156776
[TBL] [Abstract][Full Text] [Related]
16. Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co-infected patients.
Winters MA; Chary A; Eison R; Asmuth D; Holodniy M
J Med Virol; 2010 May; 82(5):791-8. PubMed ID: 20336744
[TBL] [Abstract][Full Text] [Related]
17. HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability.
Shuhart MC; Sullivan DG; Bekele K; Harrington RD; Kitahata MM; Mathisen TL; Thomassen LV; Emerson SS; Gretch DR
J Infect Dis; 2006 May; 193(9):1211-8. PubMed ID: 16586356
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
